✦ LIBER ✦

A phase I and pharmacokinetic study of irinotecan given as a 7 days continuous infusion in metastatic colorectal cancer patients pretreated with 5-FU or raltitrexed

✍ Scribed by Masi, G.; Di Paolo, A.; Allegrini, G.; Cupini, S.; Galli, C.; Barbara, C.; Danesi, R.; Del Tacca, M.; Falcone, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of topotecan given as c

✍ G. Hütter; H. Szélenyi; P. M. Deckert; U. Keilholz; E. Thiel 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 191 KB

Phase I study of gefitinib, irinotecan,

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

Phase I clinical and pharmacokinetic/pha

✍ Park, Sook Ryun; Hong, Yong Sang; Lim, Hyeong-Seok; Seong, Moon-Woo; Kong, Sun-Y 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 747 KB

A phase II study of biweekly irinotecan

✍ Salvador, J.; Bernabe, R.; Bolaños, M.; Borrega, P.; Valladares, M.; Cobo, M.; R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Results of a phase II study combining, w

✍ Gamelin, E.; Jacob, J.; Boisdron, M.; Burtin, P.; Dorval, E.; Berger, V.; Fermen 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A phase I trial of 5-day chronomodulated

✍ C. Garufi; F. Lévi; A.M. Aschelter; R. Pace; S. Giunta; C. Nisticó; D.A.P. Gallà 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 766 KB